Neuro

Radical Catheter Technologies’ 8F Neurovascular Guide Catheter Demonstrates Outstanding Clinical Performance in Initial Cases

Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting

ANACONDA Biomed Receives CE Mark for its ANA5 Funnel Catheter to Treat Ischemic Stroke

BARCELONA – June 18, 2025 – ANACONDA Biomed, a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has announced that it has received CE Mark certification for its ANA5 Funnel Catheter. The CE marking confirms that the ANA5 device complies with the European Union’s health, […]

Crossroads Neurovascular, Inc. Announces FDA 510(k) Clearance for PATH BGC™, the World’s First 7F-Compatible Balloon Guide Catheter for Neurovascular Use

Lake Forest, CA – Crossroads Neurovascular, Inc. is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K242392) for its groundbreaking PATH BGC™, a next-generation balloon guide catheter (BGC) designed to advance neurovascular intervention. With this clearance, PATH BGC becomes the world’s first BGC […]

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard® Prime EPS.

Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements

SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural Plus, the first and only comprehensive solution for quantifying the size of collections like subdural hemorrhages (SDH) in the subdural space […]

Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter

Terumo Neuro’s SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility PARIS, June 2, 2025 /PRNewswire/ — Terumo Neuro, a global leader in…